Results 91 to 100 of about 10,799 (115)

Correction: Heat shock protein 27 phosphorylation state is associated with cancer progression. [PDF]

Front Genet
Katsogiannou M, Andrieu C, Rocchi P.
europepmc   +1 more source

Second-line chemotherapy efficacy is not affected by prior exposure to immunotherapy in extensive-disease small-cell lung cancer: results from the ESME French national real-world cohort. [PDF]

ESMO Open
Gobbini E, Diallo MH, Clément-Duchene C, Chouaid C, Hiret S, Audigier-Valette C, Bizieux A, Debieuvre D, Quantin X, Le Guen Y, Lemoine A, Falchero L, Remon-Masip J, Bosquet L, Pérol M, Girard N.   +15 more
europepmc   +1 more source

Case report: incidental finding of an ectopic adrenal gland during sentinel lymph node evaluation following melanoma excision. [PDF]

Int J Surg Case Rep
Bresson M, Garbar C, Gravante G, Beulque E, Dolivet G, Mastronicola R.   +5 more
europepmc   +1 more source

Correction: Bourefis et al. HSP27/Menin Expression as New Prognostic Serum Biomarkers of Prostate Cancer Aggressiveness Independent of PSA. <i>Cancers</i> 2022, <i>14</i>, 4773. [PDF]

Cancers (Basel)
Bourefis A, Berredjem H, Djeffal O, Le TK, Giusiano S, Rocchi P.   +5 more
europepmc   +1 more source

High-Concentration Capsaicin Patch and Oral Pregabalin as Second-Line Therapy for Intercostobrachial Neuralgia After Breast Cancer Surgery: Open-Label Follow-Up of a Multicenter Randomized Controlled Clinical Trial. [PDF]

Cancers (Basel)
Dupoiron D, Bienfait F, Seegers V, Jubier-Hamon S.   +3 more
europepmc   +1 more source

Sensitive cell-free DNA assay for accurate detection of RAS and BRAF mutations in liquid biopsies of patients with metastatic colorectal cancer: Final results of the multicentric ColoBEAM study. [PDF]

Oncol Lett
Harlé A, Gavoille C, Bouché O, Abdelghani MB, Plaza J, Spaeth D, Boudrant A, Ghiringhelli F, Villing AL, Borg C, Rouyer M, Husson M, Gilson P, Salleron J, Lambert A, Merlin JL.   +15 more
europepmc   +1 more source

Obstacles et facteurs favorables à l’utilisation du plan de soins de survie par les survivants de cancers du sein et colorectaux. [PDF]

Can Oncol Nurs J
Mutsaers B, Langmuir T, MacDonald-Liska C, Presseau J, Larocque G, Harris C, Chomienne MH, Giguère L, Mairena PMG, Babiker D, Thavorn K, Lebel S.   +11 more
europepmc   +1 more source

Élaboration des normes canadiennes de soins infirmiers en thérapie cellulaire. [PDF]

Can Oncol Nurs J
Page C, Bauder A, Cosencova L, Holmes LA, Joyce S, Kozlowski M, Longworth C, Maier S, McAfee J, McLean A, Pommier R, St Jean R, Vavra A, Richer J.   +13 more
europepmc   +1 more source

Long-Term Response and Survival in Extensive-Stage SCLC Receiving Atezolizumab Plus Chemotherapy in a Real-World Setting: IFCT-1905 CLINATEZO. [PDF]

JTO Clin Res Rep
Falchero L, Amrane K, Godbert B, Leterre B, Madelaine J, Fournel P, Mascaux C, Raimbourg J, Schneider S, Swalduz A, Veillon R, Langlais A, Missy P, Morin F, Westeel V, Girard N.   +15 more
europepmc   +1 more source

Prospective pilot study with [⁸⁹Zr]Zr-girentuximab PET/CT: CA-IX imaging in metastatic triple negative breast cancer (OPALESCENCE). [PDF]

Eur J Nucl Med Mol Imaging
Rousseau C, Heyman MF, Ferrer L, Rauscher A, Morel A, Rusu D, Frenel JS, Taupin M, Vilcot L, Allam N, Robert M, Campone M, Campion L, Kraeber-Bodéré F.   +13 more
europepmc   +1 more source